InsidersTradesSigma
Track the 애드바이오텍 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 애드바이오텍 has recorded 7 public disclosures. Market capitalisation: €40.6bn. The latest transaction was reported on 18 June 2026 (Purchase). Among the most active insiders: 비케이파트너스투자조합1호. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
7 of 7 declarations
애드바이오텍 es una empresa de salud y farmacéutica cotizada en el mercado XKRX. Se especializa en el desarrollo de productos biofarmacéuticos.